Does Erlotinib Restore Chemosensitivity to Chemotherapy in Pancreatic Cancer? A Retrospective Analysis
Background Erlotinib, an Epidermal Growth Factor Receptor (EGFR) inhibitor, in combination with
Articles, journals and conferences in one search. An exact title, DOI or ISSN is listed first.
In the search box: "exact phrase" · -leave out · OR · prefix* · title: author: journal:
Background Erlotinib, an Epidermal Growth Factor Receptor (EGFR) inhibitor, in combination with
Background Erlotinib, an Epidermal Growth Factor Receptor (EGFR) inhibitor, in combination with
Pancreatic adenocarcinoma is associated with high rates of mortality due to a
For authors and organisers
Find the right journal for your paper and submit your manuscript.